Monoclonal antibody of cyprinid herpesvirus 2 (CyHV-2) ORF121 protein and application of monoclonal antibody
A technology of ORF121 and GST-ORF121, which is applied in the field of monoclonal antibodies, can solve the problems of relatively little research on detection methods
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Preparation of polyclonal antibody: The recombinant plasmids used in the present invention were stored in the laboratory of Shanghai Ocean University Pathogen Bank. Competent cells were purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd. Restriction enzymes and T4 ligase were purchased from From TaKaRa Company (ie Treasure Bioengineering (Dalian) Co., Ltd.).
[0031] ORF121 prokaryotic expression
[0032] 1.1 ORF121 gene fragment amplification
[0033] Design specific primers according to the gene sequence of CyHV-2ORF121
[0034] (F:5′-CCGGAATTCCATGTCTACAGAAATGGTTTTCATCG-3′(SEQ ID NO.1); R:5′-CCGCTCGAGTCCTACATATCGTCTTCATCCTCGGGT-3′(SEQ ID NO.2)), EcoRI and XhoI restriction sites were inserted into the upstream and downstream primer sequences respectively point. Collect the GiCF cell infection solution infected with CyHV-2 and freeze-thaw repeatedly 2-3 times, centrifuge at 4000r / min at 4°C for 20min, collect the supernatant and centrifuge at 32000r / min...
Embodiment 2
[0042] Monoclonal antibody preparation:
[0043] 2.1 SP2 / 0 mouse myeloma cells and experimental mice
[0044] The SP2 / 0 mouse myeloma cells were preserved in our laboratory, and cultured before immunization, so that they were in the logarithmic growth phase. The SPF-grade BABL / C mice used in the experiment were purchased from Shanghai Legen Biotechnology Co., Ltd., and kept in the laboratory for 7 days before immunization.
[0045] 2.2 Immunization procedure
[0046] The mice were immunized with the purified target protein in four times, 200 μl / mouse each time. For the first immunization, Freund's complete adjuvant and ORF121 recombinant protein were mixed and completely emulsified at 1:1 and injected intraperitoneally; the second immunization was carried out 14 days after the first immunization, and ORF121 recombinant protein was mixed with Freund's incomplete adjuvant The dose was mixed 1:1 and then completely emulsified and injected intraperitoneally; the third and fourt...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


